Association between psychotropic drug use and heart failure therapy in elderly long-term care residents [29]

Journal of the American Geriatrics Society

Volumn 54, Issue 12, 2006, Pages 1973-1975

  Heckman, George A ^a   Misiaszek, Brian ^a   Merali, Fatima ^b   Turpie, Irene D ^a   Patterson, Christopher J ^a   Flett, Norman ^c   McKelvie, Robert S ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b William Osler Health Center   (Canada)

^c St Joseph's Villa   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPNOTIC SEDATIVE AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

AGED; DEPRESSION; DRUG USE; ELDERLY CARE; HEART FAILURE; HUMAN; LETTER; NURSING HOME PATIENT; PRESCRIPTION;

AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANXIETY DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HOMES FOR THE AGED; HUMANS; LONG-TERM CARE; MALE; MEDICAL RECORDS; ONTARIO; PSYCHOTROPIC DRUGS; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 33845488966     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2006.00995.x     Document Type: Letter

References (10)

1. Heckman GA, Misiaszek B,Merali F et al. The management of heart failure in Canadian long-term care facilities. Can J Cardiol 2004;20:963-969.
2. Joynt KE, Whellan DJ, O'Connor CM. Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure. J Card Fail 2004;10:258-271.
3. Haworth JE, Moniz-Cook E, Clark AL et al. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular dysfunction. Eur J Heart Fail 2005;7:803-808.
4. Connolly JP, Silke B, McGavock H et al. The use of angiotensin converting enzyme inhibitors in general practice - appropriate or inappropriate? Pharmacoepidemiol Drug Saf 1998;7:331-337.
5. Ontario Drug Therapy Guidelines for Congestive Heart Failure in Primary Care. Ontario Program for Optimal Therapeutics. Kingston, Ontario, Canada: Queen's Printer of Ontario, 2000.
6. Arnold JMO, Liu P, Demers C et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Can J Cardiol 2006;22:23-45.
7. Remes J, Miettinen H, Reuanen A et al. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-321.
8. Jarrett PG, Rockwood K, Carver D et al. Illness presentation in elderly patients. Arch Intern Med 1995;155:1060-1064.
9. Miura T, Kojima R, Sugiura Y et al. Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 2000;34:427-432.
10. McGrath AM. Survey of neuroleptic prescribing in residents of nursing homes in Glasgow. BMJ 1996;312:611-612.